83.32 USD
-0.62 (-0.74%)
83.32 USD
0 (0%)
GEHC gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 184 industry peers in the Health Care Equipment & Supplies industry. While GEHC belongs to the best of the industry regarding profitability, there are concerns on its financial health. GEHC has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year GEHC was profitable.
In the past year GEHC had a positive cash flow from operations.
Each year in the past 5 years GEHC has been profitable.
In the past 5 years GEHC always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of 6.14%, GEHC belongs to the top of the industry, outperforming 84.24% of the companies in the same industry.
GEHC's Return On Equity of 22.19% is amongst the best of the industry. GEHC outperforms 95.11% of its industry peers.
GEHC's Return On Invested Capital of 7.77% is amongst the best of the industry. GEHC outperforms 83.70% of its industry peers.
The Average Return On Invested Capital over the past 3 years for GEHC is in line with the industry average of 8.82%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.14% | ||
| ROE | 22.19% | ||
| ROIC | 7.77% |
ROA(3y)5.75%
ROA(5y)16.59%
ROE(3y)21.16%
ROE(5y)34.2%
ROIC(3y)8.36%
ROIC(5y)9.41%
1.3 Margins
GEHC's Profit Margin of 10.95% is amongst the best of the industry. GEHC outperforms 84.78% of its industry peers.
In the last couple of years the Profit Margin of GEHC has grown nicely.
GEHC's Operating Margin of 13.52% is amongst the best of the industry. GEHC outperforms 81.52% of its industry peers.
GEHC's Operating Margin has been stable in the last couple of years.
The Gross Margin of GEHC (40.80%) is worse than 67.39% of its industry peers.
In the last couple of years the Gross Margin of GEHC has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.52% | ||
| PM (TTM) | 10.95% | ||
| GM | 40.8% |
OM growth 3Y-5.66%
OM growth 5Y0.88%
PM growth 3Y-7.45%
PM growth 5Y2.03%
GM growth 3Y0.74%
GM growth 5Y1.16%
2. Health
2.1 Basic Checks
GEHC has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for GEHC has been increased compared to 1 year ago.
Compared to 1 year ago, GEHC has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 1.93 indicates that GEHC is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 1.93, GEHC perfoms like the industry average, outperforming 59.24% of the companies in the same industry.
GEHC has a debt to FCF ratio of 7.38. This is a slightly negative value and a sign of low solvency as GEHC would need 7.38 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 7.38, GEHC is in the better half of the industry, outperforming 74.46% of the companies in the same industry.
A Debt/Equity ratio of 0.83 indicates that GEHC is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.83, GEHC is doing worse than 72.28% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.83 | ||
| Debt/FCF | 7.38 | ||
| Altman-Z | 1.93 |
ROIC/WACC0.98
WACC7.95%
2.3 Liquidity
GEHC has a Current Ratio of 1.18. This is a normal value and indicates that GEHC is financially healthy and should not expect problems in meeting its short term obligations.
GEHC has a Current ratio of 1.18. This is amonst the worse of the industry: GEHC underperforms 84.24% of its industry peers.
GEHC has a Quick Ratio of 1.18. This is a bad value and indicates that GEHC is not financially healthy enough and could expect problems in meeting its short term obligations.
GEHC has a Quick ratio of 0.95. This is amonst the worse of the industry: GEHC underperforms 80.43% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.18 | ||
| Quick Ratio | 0.95 |
3. Growth
3.1 Past
GEHC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.77%, which is quite good.
The Earnings Per Share has been growing slightly by 5.32% on average over the past years.
Looking at the last year, GEHC shows a small growth in Revenue. The Revenue has grown by 3.52% in the last year.
The Revenue has been growing slightly by 3.41% on average over the past years.
EPS 1Y (TTM)8.77%
EPS 3Y-4.21%
EPS 5Y5.32%
EPS Q2Q%-6.14%
Revenue 1Y (TTM)3.52%
Revenue growth 3Y3.81%
Revenue growth 5Y3.41%
Sales Q2Q%5.76%
3.2 Future
The Earnings Per Share is expected to grow by 7.54% on average over the next years.
GEHC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.87% yearly.
EPS Next Y2.61%
EPS Next 2Y5.64%
EPS Next 3Y7.61%
EPS Next 5Y7.54%
Revenue Next Year4.15%
Revenue Next 2Y4.27%
Revenue Next 3Y4.33%
Revenue Next 5Y3.87%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
GEHC is valuated rather expensively with a Price/Earnings ratio of 18.15.
Based on the Price/Earnings ratio, GEHC is valued cheaper than 82.61% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.50. GEHC is valued slightly cheaper when compared to this.
A Price/Forward Earnings ratio of 16.63 indicates a correct valuation of GEHC.
84.78% of the companies in the same industry are more expensive than GEHC, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of GEHC to the average of the S&P500 Index (23.93), we can say GEHC is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.15 | ||
| Fwd PE | 16.63 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, GEHC is valued cheaper than 84.24% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of GEHC indicates a rather cheap valuation: GEHC is cheaper than 82.61% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 27.11 | ||
| EV/EBITDA | 13.47 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of GEHC may justify a higher PE ratio.
PEG (NY)6.94
PEG (5Y)3.41
EPS Next 2Y5.64%
EPS Next 3Y7.61%
5. Dividend
5.1 Amount
With a yearly dividend of 0.17%, GEHC is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 0.20, GEHC pays a better dividend. On top of this GEHC pays more dividend than 89.67% of the companies listed in the same industry.
With a Dividend Yield of 0.17, GEHC pays less dividend than the S&P500 average, which is at 1.87.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.17% |
5.2 History
GEHC has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
GEHC pays out 2.80% of its income as dividend. This is a sustainable payout ratio.
DP2.8%
EPS Next 2Y5.64%
EPS Next 3Y7.61%
83.32
-0.62 (-0.74%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners89.07%
Inst Owner Change0.96%
Ins Owners0.28%
Ins Owner Change-0.04%
Market Cap37.95B
Revenue(TTM)20.25B
Net Income(TTM)2.22B
Analysts79.29
Price Target89.57 (7.5%)
Short Float %2.45%
Short Ratio3.02
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.17% |
Yearly Dividend0.12
Dividend Growth(5Y)N/A
DP2.8%
Div Incr Years1
Div Non Decr Years1
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)6.54%
Min EPS beat(2)-0.16%
Max EPS beat(2)13.24%
EPS beat(4)3
Avg EPS beat(4)8.5%
Min EPS beat(4)-0.16%
Max EPS beat(4)13.24%
EPS beat(8)6
Avg EPS beat(8)5.72%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-0.92%
Min Revenue beat(2)-1.09%
Max Revenue beat(2)-0.75%
Revenue beat(4)1
Avg Revenue beat(4)-0.9%
Min Revenue beat(4)-2.17%
Max Revenue beat(4)0.42%
Revenue beat(8)2
Avg Revenue beat(8)-1.64%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.92%
PT rev (3m)0.93%
EPS NQ rev (1m)-0.77%
EPS NQ rev (3m)-0.55%
EPS NY rev (1m)-0.72%
EPS NY rev (3m)-0.1%
Revenue NQ rev (1m)-0.03%
Revenue NQ rev (3m)-0.17%
Revenue NY rev (1m)-0.07%
Revenue NY rev (3m)0.23%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.15 | ||
| Fwd PE | 16.63 | ||
| P/S | 1.87 | ||
| P/FCF | 27.11 | ||
| P/OCF | 20.52 | ||
| P/B | 3.8 | ||
| P/tB | N/A | ||
| EV/EBITDA | 13.47 |
EPS(TTM)4.59
EY5.51%
EPS(NY)5.01
Fwd EY6.01%
FCF(TTM)3.07
FCFY3.69%
OCF(TTM)4.06
OCFY4.87%
SpS44.45
BVpS21.94
TBVpS-10.12
PEG (NY)6.94
PEG (5Y)3.41
Graham Number47.6
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.14% | ||
| ROE | 22.19% | ||
| ROCE | 10.51% | ||
| ROIC | 7.77% | ||
| ROICexc | 9.18% | ||
| ROICexgc | 27.2% | ||
| OM | 13.52% | ||
| PM (TTM) | 10.95% | ||
| GM | 40.8% | ||
| FCFM | 6.91% |
ROA(3y)5.75%
ROA(5y)16.59%
ROE(3y)21.16%
ROE(5y)34.2%
ROIC(3y)8.36%
ROIC(5y)9.41%
ROICexc(3y)9.28%
ROICexc(5y)10.16%
ROICexgc(3y)32.48%
ROICexgc(5y)41.69%
ROCE(3y)11.31%
ROCE(5y)12.72%
ROICexgc growth 3Y-14.77%
ROICexgc growth 5YN/A
ROICexc growth 3Y-4.79%
ROICexc growth 5YN/A
OM growth 3Y-5.66%
OM growth 5Y0.88%
PM growth 3Y-7.45%
PM growth 5Y2.03%
GM growth 3Y0.74%
GM growth 5Y1.16%
F-Score5
Asset Turnover0.56
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.83 | ||
| Debt/FCF | 7.38 | ||
| Debt/EBITDA | 2.51 | ||
| Cap/Depr | 78.67% | ||
| Cap/Sales | 2.22% | ||
| Interest Coverage | 5.09 | ||
| Cash Conversion | 55.91% | ||
| Profit Quality | 63.15% | ||
| Current Ratio | 1.18 | ||
| Quick Ratio | 0.95 | ||
| Altman-Z | 1.93 |
F-Score5
WACC7.95%
ROIC/WACC0.98
Cap/Depr(3y)60.52%
Cap/Depr(5y)52.47%
Cap/Sales(3y)1.9%
Cap/Sales(5y)1.73%
Profit Quality(3y)98.54%
Profit Quality(5y)74.63%
High Growth Momentum
Growth
EPS 1Y (TTM)8.77%
EPS 3Y-4.21%
EPS 5Y5.32%
EPS Q2Q%-6.14%
EPS Next Y2.61%
EPS Next 2Y5.64%
EPS Next 3Y7.61%
EPS Next 5Y7.54%
Revenue 1Y (TTM)3.52%
Revenue growth 3Y3.81%
Revenue growth 5Y3.41%
Sales Q2Q%5.76%
Revenue Next Year4.15%
Revenue Next 2Y4.27%
Revenue Next 3Y4.33%
Revenue Next 5Y3.87%
EBIT growth 1Y8.91%
EBIT growth 3Y-2.07%
EBIT growth 5Y4.33%
EBIT Next Year18.09%
EBIT Next 3Y10.97%
EBIT Next 5Y9.55%
FCF growth 1Y-18.75%
FCF growth 3Y4.48%
FCF growth 5Y0.56%
OCF growth 1Y-11.61%
OCF growth 3Y6.68%
OCF growth 5Y1.2%
GE HEALTHCARE TECHNOLOGY / GEHC FAQ
What is the fundamental rating for GEHC stock?
ChartMill assigns a fundamental rating of 5 / 10 to GEHC.
What is the valuation status of GE HEALTHCARE TECHNOLOGY (GEHC) stock?
ChartMill assigns a valuation rating of 6 / 10 to GE HEALTHCARE TECHNOLOGY (GEHC). This can be considered as Fairly Valued.
How profitable is GE HEALTHCARE TECHNOLOGY (GEHC) stock?
GE HEALTHCARE TECHNOLOGY (GEHC) has a profitability rating of 7 / 10.
Can you provide the PE and PB ratios for GEHC stock?
The Price/Earnings (PE) ratio for GE HEALTHCARE TECHNOLOGY (GEHC) is 18.15 and the Price/Book (PB) ratio is 3.8.
Can you provide the financial health for GEHC stock?
The financial health rating of GE HEALTHCARE TECHNOLOGY (GEHC) is 3 / 10.